Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_assertion type Assertion NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_head.
- NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_assertion description "[Homozygous deletion, a combination of LOH and promoter hypermethylation, and multiple LOH are major mechanisms of p16 inactivation in gallbladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_provenance.
- NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_assertion evidence source_evidence_literature NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_provenance.
- NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_assertion SIO_000772 18081229 NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_provenance.
- NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_assertion wasDerivedFrom lhgdn-20090331 NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_provenance.
- NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_assertion wasGeneratedBy ECO_0000203 NP208926.RAx9n2He_LFEqklMGSYQhcsdNyGpFK0ZUAROrPcoeKjcA130_provenance.